What biomarker tests are recommended for Brain Cancer

Biomarker Testing for Brain Cancer

Biomarker testing is an important part of understanding your brain tumor and planning treatment. Let me explain what these tests are and which ones doctors typically recommend.

What Are Biomarkers?

Biomarkers are specific changes in your tumor cells—usually mutations (abnormal changes in DNA) or proteins—that provide information about how your cancer behaves and how it might respond to treatment. According to the NCCN Guidelines for Central Nervous System Cancers, biomarker testing can improve diagnostic accuracy and help fine-tune your treatment options.

Key Biomarkers Tested for Gliomas (Brain Tumors)

The NCCN Guidelines recommend testing for several important biomarkers:

IDH Mutation Status (Most Important)

• What it is: A change in the IDH gene that affects how tumor cells behave
• Why it matters: IDH mutations are strongly associated with better prognosis and may influence treatment decisions
• Detection: Identified through sequencing or immunohistochemistry (IHC)

1p/19q Codeletion

• What it is: Loss of parts of chromosomes 1 and 19
• Why it matters: This finding, combined with other markers, helps classify your tumor type and predict how it will behave
• Detection: Detected through fluorescence in situ hybridization (FISH) or sequencing

MGMT Promoter Methylation

• What it is: A chemical modification in the MGMT gene
• Why it matters: Patients whose tumors have MGMT methylation tend to respond better to temozolomide (a chemotherapy drug)
• Detection: Identified through methylation-specific PCR or sequencing

ATRX Mutation

• What it is: A loss-of-function mutation in the ATRX gene
• Why it matters: ATRX mutations are strongly associated with IDH mutations and help distinguish between tumor types (astrocytoma vs. oligodendroglioma)
• Detection: Detected by immunohistochemistry (IHC) or sequencing

TERT Promoter Mutation

• What it is: A mutation in the TERT gene that controls telomerase (an enzyme involved in cell division)
• Why it matters: TERT mutations are nearly always present in certain tumor types and can affect prognosis
• Detection: Identified through sequencing

TP53 Mutation

• What it is: A mutation in the tumor suppressor gene TP53
• Why it matters: Helps classify tumor type and can indicate more aggressive behavior in some cases
• Detection: Identified through sequencing

BRAF Mutation or Fusion

• What it is: An activating change in the BRAF gene
• Why it matters: BRAF mutations may respond to targeted therapies like vemurafenib
• Detection: Identified through sequencing or RNA sequencing for fusions

H3-3A Mutation (H3K27M)

• What it is: A histone mutation found primarily in midline brain tumors
• Why it matters: Indicates a specific tumor type and is associated with more aggressive behavior
• Detection: Identified through sequencing or specialized immunostaining

Important Clinical Context

According to the NCCN Guidelines, molecular/genetic characterization complements but does not replace standard histologic (microscopic) examination. Your pathologist will combine:

• How the tumor looks under the microscope
• Biomarker test results
• Your clinical presentation

This integrated approach provides the most accurate diagnosis and helps guide treatment decisions.

Questions to Ask Your Healthcare Team

1. Which biomarker tests have been performed on my tumor tissue?
2. Are there additional biomarker tests available that haven't been done yet? (Some hospitals can send tissue to specialized labs for more comprehensive testing)
3. What do my specific biomarker results mean for my diagnosis and treatment options?
4. Are there any targeted therapies available based on my biomarker profile?
5. If my tumor tissue is limited, how do we prioritize which tests are most important?

Access to Testing

The NCCN Guidelines note that not all hospitals can provide a full range of biomarker tests. If your current facility has limitations, you can request that your tissue sample be sent to another laboratory for more comprehensive testing. This is an important right—don't hesitate to ask about this option.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.